William Owen

"I am quite fortunate to work in an environment where we can provide state-of-the-art medical care to our patients while at the same time participate in clinical research and education of our future healthcare providers."

Dr. William Owen

(757) 668-7243

Practice
Board Certifications

American Board of Pediatrics

Pediatric Hematology-Oncology

Education

Medical School: Bowman Gray School of Medicine

Residency: Children's National Medical Center

Fellowship: Children's National Medical Center

Bio
Dr. Owen graduated from the University of North Carolina at Chapel Hill with a degree in zoology and psychology, and he remains an avid Tar Heel fan.  He has served as the leader in the development of several clinical programs at CHKD, including the peripheral stem cell transplantation and comprehensive sickle cell programs.  He has also served in various roles on regional, state and national committees ranging from chairman of the EVMS admissions committee to a participant on the sickle cell disease expert panel for development of quality of care indicators at Boston University.
Research areas
  • Interventions to prevent primary and secondary stroke in sickle cell disease
  • Novel drugs to decrease the complications associated with sickle cell disease
  • Implementation of state-of-the-art medical therapies in underdeveloped countries
Clinical interests
  • General pediatric hematology/oncology
  • Leukemia
  • Sickle cell disease
  • Immunological diseases which affect the blood and bone marrow
  • Histiocytic diseases
Honors & awards
  • Coastal Virginia Magazine "Top Doc" 2014
  • Alpha Omega Alpha Honor Medical Society
  • Named as one of the "Top Doctors in Hampton Roads"
Community involvement
Dr. Owen has a strong interest in global health and has made multiple trips to Haiti and the Dominican Republic to provide direct health care, to help establish medical screening programs, and to aid in the educational process of local medical providers.
Publications
Alvarez O, Yovetich NA, Scott JP, Owen W, et.al. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. American Journal of Hematology. 2013 Nov:88(11):932-938.

McCarville M, Rogers Z, Sarnaik S, Scott P, Aygun B, Hilliard L, Lee M, Kalinyak M, Owen W, et. al. Effects of Chronic Transfusions on Abdominal Sonographic Abnormalities in Children with Sickle Cell Anemia. Journal of Pediatrics. 2012 Feb;160(2):281-285.

Fung E, Harmatz P, Milet M, Ballas S, Decastro L, Hagar W, Hilliard L, Owen W, et al. Morbidity and Mortality in Transfused Subjects with Thalassemia and Sickle Cell Disease: A Report of the Multicenter Iron Overload Study. American Journal of Hematology 2007 Apr;82(4):255-265.

Whitlock J, Krailo M, Reid J, Ruben S, Ames M, Owen W, and Reaman G. Phase I Clinical and Pharmacokinetic Study of Flavopiridol in Children with Refractory Solid Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology 2005:Dec 23(36):9179-9186.

(757) 668-7243

A Mother's Story

When Audrey Dembitz was born with a tumor in her abdomen, her parents turned to Dr. William Owen for answers.

+Read More

More Than A Hospital